26 / 76
CARDIOVASCULAR JOURNAL OF AFRICA • Volume 29, No 4, July/August 2018
224
AFRICA
22. Havranek E, Esler A, Estacio RO, Mehler PS, Schrier RW. Differential
effects of antihypertensive agents on electrocardiographic voltage:
results from the Appropriate Blood Pressure Control in Diabetes
(ABCD) trial.
Am Heart J
2003;
145
(6): 993–998.
23. Keil JE, Sutherland SE, Knapp RG, Lackland DT, Gazes PG, Tyroler
HA. Mortality rates and risk factors for coronary disease in black as
compared with white men and women.
N Engl J Med
1993;
329
: 738.
24. Collins R, Peto R, MacMahon S, Herbert P, Fiebach N, Eberlein K,
et al.
Blood pressure, stroke, and coronary heart disease.
Lancet
1990;
335
: 827–838.
25. Lawes CM, van der Hoorn S, Rodgers A. Global burden of blood-
pressure related disease, 2001.
Lancet
2008;
371
: 1513–1518.
26. Yach D, Hawkes C, Gould CL, Hofman KJ. The global burden of
chronic diseases: overcoming impediments to prevention and control.
J
Am Med Assoc
2004;
291
: 2616–2622.
27. Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H,
et
al.
A comparative risk assessment of burden of disease and injury attrib-
utable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010:
a systematic analysis for the Global Burden of Disease Study 2010.
Lancet
2012;
380
: 2224–2260.
28. Daskalopoulou SS, Rabi DM, Prebtani A,
et al
. The 2015 Canadian
Hypertension Education Program recommendations for blood pressure
measurement, diagnosis, assessment of risk, prevention, and treatment
of hypertension.
Can J Cardiol
2015;
31
: 549–568.
29. Mensah GA. Epidemiology of stroke and high blood pressure in Africa.
Heart
2008;
94
: 697–705.
30. Opie LH, Seedat YK. Hypertension in sub-Saharan African popula-
tions.
Circulation
2005;
112
: 3562–3568.
31. Addo J, Smeeth L, Leon DA. Hypertension in sub-Saharan Africa: a
systematic review
Hypertension
2007;
50
: 1012–1018.
32. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka
PA,
et al.
Recommendations for chamber quantification: A report from
the American Society of Echocardiography’s Guidelines and Standards
Committee and the Chamber Quantification Writing Group, developed
in conjunction with the European Association of Echocardiography, a
branch of the European Society of Cardiology.
J Am Soc Echocardiogr
2005;
18
: 1440–1463.
33. Drawz PE, Abdalla M, Rahman M. Blood pressure measurement: clinic,
home, ambulatory, and beyond.
Am J Kidney Dis
2012;
60
(3): 449–462.
34. Schwartz JI, Guwatudde D, Nugent R, Kiiza KM. Looking at non-
communicable diseases in Uganda through a local lens: an analysis using
locally derived data.
Glob Health
2014;
10
: 77.
35. Mayega RW, Makumbi F, Rutebemberwa E, Peterson S, Ostenson CG,
Tomson G,
et al
. Modifiable socio-behavioural factors associated with
overweight and hypertension among persons aged 35 to 60 years in
eastern Uganda.
PLoS One
2012;
7
: e47632.
36. Mayega RW, Guwatudde D, Makumbi FE, Nakwagala FN, Peterson
S, Tomson G,
et al
. Comparison of fasting plasma glucose and haemo-
globin A1c point-of-care tests in screening for diabetes and abnormal
glucose regulation in a rural low income setting.
Diabetes Res Clin Pract
2014;
104
: 112–120.
37. Wamala J, Karyabakabo Z, Ndungutse D, Guwatudde D. Prevalence
factors associated with hypertension in Rukungiri District, Uganda – A
community-based study.
Afr Health Sci
2009;
9
: 153–160.
38. Damasceno A, Azevedo A, Siva matos C, Prista A, Diogo D,
et
al.
Hypertension prevalence, awareness, treatment, and control in
Mozambique (urban/rural gap during epidemiological transition).
Hypertension
2009;
54
: 77–83.
39. Agyemang C, Bruijnzeels MA, Owusu-Dabo E. Factors associated with
hypertension awareness, treatment, and control in Ghana, West Africa.
J Hum Hypertens
2005;
20
: 67–71.
40. Pereira M, Lunet N, Azevedo A, Barros H. Differences in prevalence,
awareness, treatment and control of hypertension between developing
and developed countries.
J Hypertens
2009;
27
: 963–975.
41. Tumwesigye E, Wana G, Kasasa S, Muganzi E, Nuwaha F. High uptake
of home-based, district-wide, HIV counseling and testing in Uganda.
A
IDS Patient Care STDS
2010;
24
: 735–741.
42. Menzies N, Abang B, Wanyeze R, Nuwaha F, Mugisha B,
et al
. The
costs and effectiveness of four HIV counselling and testing strategies in
Uganda.
AIDS Patient Care STDS
2009;
23
: 395–401.
43. Kibirige D, Atuhe D, Sebunya R, Mwebaze R. Suboptimal glycaemic
and blood pressure control and screening for diabetic complications
in adult ambulatory diabetic patients in Uganda: a retrospective study
from a developing country.
J Diabetes Metab Dis
2014;
13
: 40.
44. Psaltopoulou T, Orfanos P, Naska A, Lenas D, Trichopoulos D,
et
al
. Prevalence, awareness, treatment and control of hypertension in a
general population sample of 26 913 adults in the Greek EPIC study.
Int J Epidemiol
2004;
33
: 1345–1352.
45. Dzudie A, Kengne AP, Muna WF, Ba H, Menanga A,
et al.
Prevalence,
awareness, treatment and control of hypertension in a self-selected sub-
Saharan Africa urban population: a cross-sectional study.
Br Med J
Open
2012;
2
: 2012–001217.
46. Reisin E, Harris RC, Rahman M. Commentary on the 2014 BP guide-
lines from the panel appointed to the Eighth Joint National Committee
(JNC 8).
J Am Soc Nephrol
2014: ASN. 2014040371.
47. Walker R, Whiting D, Unwin N, Mugusi F, Swai M,
et al
. Stroke inci-
dence in rural and urban Tanzania: a prospective, community-based
study.
Lancet Neurol
2010;
9
: 786–792.
48. Walker RW, McLarty DG, Kitange HM, Whiting D, Masuki G,
et
al.
Stroke mortality in urban and rural Tanzania.
Lancet
2000;
355
:
1684–1687.
49. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJL.
Global
Burden of Disease and Risk Factors
. New York: The World Bank and
Oxford University Press, 2006.
50. Wild S, Roglic G, Green A, Sicree R. King. Global prevalence of diabe-
tes: estimates for 2000 and projections for 2030.
Diabetes Care
2004;
20
:
1047–1053.
51. Okpere AN, Anochie IC, Eke FU. Prevalence of microalbuminuria
among secondary school children.
Afr Health Sci
2012;
12
(2): 140–147.